In this episode, Steven Ringel, CEO of the Kazuna Foundation and Nome Therapeutics, joins the podcast to discuss how his team is using artificial intelligence to make personalized medicine accessible for rare disease patients. He shares emerging trends in AI and healthcare, the growing potential of individualized therapies, and his advice for passionate leaders driving innovation in the field.
Using AI to Power Custom Treatments for Rare Diseases with Steven Ringel
Next Up in Becker's Healthcare Podcast Episodes
-
In this episode, Matthew Ray Scott, MS, Principal & Managing Director, FEED. The Agency, and Scott Sigman,MD, Orthopedic Surgeon, Podcaster,…
-
In this episode, Kyle Clifford, Chief Executive Officer at amfAR, discusses the organization’s mission to fund groundbreaking early stage HIV…
-
In this episode, Matthew Ray Scott, MS, Principal & Managing Director, FEED. The Agency, and Scott Sigman,MD, Orthopedic Surgeon, Podcaster,…
Comments are closed.